Urokinase receptor primes cells to proliferate in response to epidermal growth factor

Oncogene

Volumn 26, Issue 18, 2007, Pages 2585-2594

  Jo, M ^a   Thomas, K S ^b   Takimoto, S ^a   Gaultier, A ^a   Hsieh, E H ^a   Lester, R D ^a   Gonias, S L ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c Src; Epidermal growth factor; ERK; STAT5b; Urokinase receptor

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STAT5B PROTEIN; SYNTHETIC PEPTIDE; TYROSINE; TYROSINE DERIVATIVE; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING;

ANIMALS; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMANS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASMINOGEN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; STAT5 TRANSCRIPTION FACTOR; TYROSINE; URINARY PLASMINOGEN ACTIVATOR;

MURINAE;

EID: 34247340196     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210066     Document Type: Article

References (42)

1. Abram CL, Courtneidge SA. (2000). Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254: 1-13.
2. Aguirre Ghiso JA, Kovalski K, Ossowski L. (1999). Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89-104.
3. Angelucci A, Gravina GL, Rucci N, Millimaggi D, Festuccia C, Muzi P et al. (2006). Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice. Endocr Relat Cancer 13: 197-210.
4. Biscardi JS, Belsches AP, Parsons SJ. (1998). Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog 21: 261-272.
5. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ. (2000). Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res 2: 203-210.
6. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. (1999). c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274: 8335-8343.
7. Blasi F, Carmeliet P. (2002). uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932-943.
8. Boerner JL, Demory ML, Silva C, Parsons SJ. (2004). Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 24: 7059-7071.
9. Bolla M, Chedin M, Souvignet C, Marron J, Arnould C, Chambaz E. (1990). Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors. Breast Cancer Res Treat 16: 97-102.
10. Daub H, Weiss FU, Wallasch C, Ullrich A. (1996). Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560.
11. Deutsch DG, Mertz ET. (1970). Plasminogen: purification from human plasma by affinity chromatography. Science 170: 1095-1096.
12. Duffy MJ, Maguire TM, McDermott EW, O'Higgins N. (1999). Urokinase plasminogen activator: a prognostic marker in multiple types of cancer. J Surg Oncol 71: 130-135.
13. Estreicher A, Wohlwend A, Belin D, Schleuning WD, Vassalli JD. (1989). Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem 264: 1180-1189.
14. Jo M, Thomas KS, Marozkina N, Amin TJ, Silva CM, Parsons SJ et al. (2005). Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J Biol Chem 280: 17449-17457.
15. Jo M, Thomas KS, O'Donnell DM, Gonias SL. (2003). Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 278: 1642-1646.
16. Kim H, Chan R, Dankort DL, Zuo D, Najoukas M, Park M et al. (2005). The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene 24: 7599-7607.
17. Kiyan J, Kiyan R, Haller H, Dumler I. (2005). Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J 24: 1787-1797.
18. Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ, Silva CM. (2003). STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor. J Biol Chem 278: 1671-1679.
19. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR. (1997). Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem 272: 28563-28567.
20. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L. (2002). EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1: 445-457.
21. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ. (1997). Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem 272: 4637-4644.
22. Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM et al. (2002). Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol 159: 1061-1070.
23. Ma Z, Webb DJ, Jo M, Gonias SL. (2001). Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. J Cell Sci 114: 3387-3396.
24. Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA et al. (2004). DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp Cell Res 299: 91-100.
25. Mazzieri R, Furlan F, D'lessio S, Zonari E, Talotta F, Verde P et al. (2006). A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts. Oncogene [e-pub ahead of print].
26. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z et al. (1995). Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337-341.
27. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. (1996). Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 135: 1633-1642.
28. Monaghan-Benson E, McKeown-Longo PJ. (2006). Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor. J Biol Chem 281: 9450-9459.
29. Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L et al. (1998). Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J 17: 6622-6632.
30. Nguyen DH, Hussaini IM, Gonias SL. (1998). Binding of urokinase-type plasminogen activator to its receptor in MCF-7cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem 273: 8502-8507.
31. Nguyen DH, Webb DJ, Catling AD, Song Q, Dhakephalkar A, Weber MJ et al. (2000). Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem 275: 19382-19388.
32. O'Reilly DR. (1986). p53 and transformation by SV40. Biol Cell 57: 187-196.
33. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C et al. (1999). EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888.
34. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M et al. (2002). The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 99: 1359-1364.
35. Singh AB, Harris RC. (2005). Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17: 1183-1193.
36. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D et al. (1995). Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234.
37. Tice DA, Biscardi JS, Nickles AL, Parsons SJ. (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci USA 96: 1415-1420.
38. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL. (1997). Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem 272: 14372-14379.
39. Wei Y, Eble JA, Wang Z, Kreidberg JA, Chapman HA. (2001). Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell 12: 2975-2986.
40. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV et al. (1996). Regulation of integrin function by the urokinase receptor. Science 273: 1551-1555.
41. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M et al. (1997). Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390: 91-96.
42. Yan Y, Shirakabe K, Werb Z. (2002). The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158: 221-226.